<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 18, 2026 at 2:21 am by All in One SEO v4.5.6 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://appilitherapeutics.com/default-sitemap.xsl?sitemap=root"?>
<urlset
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:xhtml="http://www.w3.org/1999/xhtml"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/]]></loc>
		<lastmod><![CDATA[2025-07-04T13:58:32+00:00]]></lastmod>
		<changefreq><![CDATA[always]]></changefreq>
		<priority><![CDATA[1]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/04/Appili-Banner-3.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/infectious.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/img.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/img-3.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/img-4.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/img-5.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/Img-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/img-7.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/arrow-up-right.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/blog/]]></loc>
		<lastmod><![CDATA[2022-12-30T05:36:19+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2026/03/30/appili-therapeutics-to-exhibit-at-world-vaccine-congress-washington/]]></loc>
		<lastmod><![CDATA[2026-03-30T11:24:57+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2026/02/18/appili-therapeutics-announces-closing-of-second-tranche-of-non-brokered-private-placement/]]></loc>
		<lastmod><![CDATA[2026-02-18T12:20:07+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/financial-reports/]]></loc>
		<lastmod><![CDATA[2026-02-17T17:27:34+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2026/02/12/appili-therapeutics-reports-financial-and-operational-results-for-third-quarter-of-fiscal-year-2026/]]></loc>
		<lastmod><![CDATA[2026-02-12T23:15:21+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/12/18/appili-therapeutics-announces-closing-of-first-tranche-of-non-brokered-private-placement/]]></loc>
		<lastmod><![CDATA[2025-12-18T12:48:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/11/13/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2026/]]></loc>
		<lastmod><![CDATA[2025-11-13T22:29:31+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/11/05/appili-therapeutics-announces-proposed-non-brokered-private-placement/]]></loc>
		<lastmod><![CDATA[2025-11-05T12:19:58+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/10/22/appili-therapeutics-to-attend-barda-innovation-symposium-2025/]]></loc>
		<lastmod><![CDATA[2025-10-22T11:27:08+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/02/13/appili-therapeutics-announces-pricing-of-overnight-marketed-equity-offering-3/]]></loc>
		<lastmod><![CDATA[2025-10-08T13:34:09+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/10/01/appili-therapeutics-and-its-partner-vitalex-biosciences-awarded-contract-from-niaid-valued-at-up-to-us40-million-to-develop-fungal-vaccine-vxv-01/]]></loc>
		<lastmod><![CDATA[2025-10-01T11:25:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/09/23/appili-therapeutics-announces-results-of-annual-and-special-meeting-of-shareholders-3/]]></loc>
		<lastmod><![CDATA[2025-09-23T21:06:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/09/09/appili-therapeutics-to-present-progress-on-tularemia-biodefense-vaccine-at-nato-cbrn-conference/]]></loc>
		<lastmod><![CDATA[2025-09-09T11:20:35+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/proxy-info/]]></loc>
		<lastmod><![CDATA[2025-08-15T16:24:40+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2025/08/AGSM-2024-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2025/08/Proxy-2025.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/08/14/appili-therapeutics-reports-financial-and-operational-results-for-first-quarter-of-fiscal-year-2026/]]></loc>
		<lastmod><![CDATA[2025-08-14T21:11:26+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/news/]]></loc>
		<lastmod><![CDATA[2025-08-06T11:36:50+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/08/06/appili-therapeutics-and-colleagues-publish-manuscript-demonstrating-efficacy-of-ati-1701-tularemia-vaccine/]]></loc>
		<lastmod><![CDATA[2025-08-06T11:35:17+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/leadership/]]></loc>
		<lastmod><![CDATA[2025-07-04T13:58:52+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/0003_Layer-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/0002_3d295b_9f30652839094818b6cb704be9cc463a_mv2-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/04/Gary-Nabors-ircle-e1713450866151.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/Group-3.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/Group-7.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/ProfilePictureMaker-3.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/sedar-filings/]]></loc>
		<lastmod><![CDATA[2025-06-25T22:09:35+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/06/25/appili-therapeutics-reports-fiscal-year-2025-financial-and-operational-results/]]></loc>
		<lastmod><![CDATA[2025-06-25T21:36:39+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/05/30/appili-therapeutics-announces-formal-termination-of-arrangement-agreement-with-aditxt-inc/]]></loc>
		<lastmod><![CDATA[2025-05-30T11:19:48+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/05/19/appili-therapeutics-provides-update-on-arrangement-with-aditxt-inc/]]></loc>
		<lastmod><![CDATA[2025-05-19T12:05:32+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/05/01/appili-therapeutics-and-colleagues-publish-manuscript-on-the-prevention-and-emergency-response-to-tularemia/]]></loc>
		<lastmod><![CDATA[2025-05-01T11:43:28+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/04/28/appili-therapeutics-announces-new-patents-granted-for-commercial-stage-asset-likmez/]]></loc>
		<lastmod><![CDATA[2025-04-28T12:23:15+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/03/18/appili-therapeutics-announces-submission-of-u-s-federal-government-funding-proposals-and-provides-corporate-and-aditxt-transaction-update/]]></loc>
		<lastmod><![CDATA[2025-04-11T17:15:21+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/04/02/appili-president-and-ceo-don-cilla-to-join-aditxt-ceo-amro-albanna-for-aditxt-weekly-update-on-april-4-2025/]]></loc>
		<lastmod><![CDATA[2025-04-02T12:19:39+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2025/02/14/appili-therapeutics-reports-financial-and-operational-results-for-third-quarter-of-fiscal-year-2025/]]></loc>
		<lastmod><![CDATA[2025-02-14T22:08:00+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/news-2025/]]></loc>
		<lastmod><![CDATA[2025-02-14T21:24:25+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/06/Appili-Banner-3.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/events-and-presentations/]]></loc>
		<lastmod><![CDATA[2024-12-06T17:14:31+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/04/Screenshot-2023-04-11-094151.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/WVCC.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2024/12/CBD-ST.jpg]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/04/IDWeek.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2024/12/MHSRS.jpg]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/11/19/appili-therapeutics-announces-receipt-of-final-court-order-for-arrangement-with-aditxt-inc/]]></loc>
		<lastmod><![CDATA[2024-11-19T12:18:58+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/11/14/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2025/]]></loc>
		<lastmod><![CDATA[2024-11-14T12:16:42+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/news-2024/]]></loc>
		<lastmod><![CDATA[2024-11-06T23:01:05+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/06/Appili-Banner-3.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/11/06/appili-therapeutics-announces-results-of-special-meeting-of-shareholders/]]></loc>
		<lastmod><![CDATA[2024-11-06T22:55:50+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/10/31/appili-therapeutics-announces-alignment-with-fda-on-development-requirements-for-ati-1801-topical-antiparasitic-product-nda-submission/]]></loc>
		<lastmod><![CDATA[2024-10-31T11:24:15+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/10/17/appili-therapeutics-presents-update-on-ati-1701-biodefense-vaccine-candidate-at-idweek-2024/]]></loc>
		<lastmod><![CDATA[2024-10-17T11:20:27+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/highlights/]]></loc>
		<lastmod><![CDATA[2024-10-11T15:06:32+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/img3.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/img5.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/svg5.svg]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/img2.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/10/10/appili-therapeutics-announces-mailing-of-the-management-information-circular-in-connection-with-the-special-meeting-of-shareholders/]]></loc>
		<lastmod><![CDATA[2024-10-10T18:06:47+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/09/17/appili-therapeutics-announces-results-of-annual-and-special-meeting-of-shareholders-2/]]></loc>
		<lastmod><![CDATA[2024-09-17T21:13:29+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/08/21/appili-therapeutics-announces-third-amendment-to-arrangement-agreement-and-provides-updated-on-transaction-with-aditxt/]]></loc>
		<lastmod><![CDATA[2024-08-21T11:40:04+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/08/13/appili-therapeutics-reports-financial-and-operational-results-for-first-quarter-of-fiscal-year-2025/]]></loc>
		<lastmod><![CDATA[2024-08-13T21:26:07+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/board-of-directors/]]></loc>
		<lastmod><![CDATA[2024-08-12T19:30:20+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/02/Group-6.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/02/Group-9.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/02/Group-7.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/02/Group-4.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/11/prakash-2-2-e1714414210149.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/02/Group-8.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/07/18/appili-therapeutics-announces-second-amendment-to-arrangement-agreement/]]></loc>
		<lastmod><![CDATA[2024-07-18T21:10:09+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/07/02/appili-therapeutics-announces-amendment-to-arrangement-agreement-and-increase-to-bridge-loan/]]></loc>
		<lastmod><![CDATA[2024-07-02T11:37:35+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/06/25/appili-therapeutics-reports-fiscal-year-2024-financial-and-operational-results/]]></loc>
		<lastmod><![CDATA[2024-06-25T21:52:08+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/about/]]></loc>
		<lastmod><![CDATA[2024-04-29T18:08:35+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/04/26/appili-therapeutics-announces-additional-bridge-loan-from-bloom-burton-co/]]></loc>
		<lastmod><![CDATA[2024-04-26T23:18:18+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/pipeline/]]></loc>
		<lastmod><![CDATA[2024-04-10T17:01:56+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2024/04/Pipeline-240410.jpg]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/06/Screenshot-2023-06-01-101908.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/Group-95.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/arrow-up-right.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/04/02/appili-therapeutics-signs-definitive-agreement-to-be-acquired-by-aditxt-inc/]]></loc>
		<lastmod><![CDATA[2024-04-02T12:02:44+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/03/12/researchers-publish-manuscript-on-the-prevention-and-emergency-response-to-tularemia-outbreaks/]]></loc>
		<lastmod><![CDATA[2024-03-12T11:27:49+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2024/02/13/appili-therapeutics-reports-financial-and-operational-results-for-third-quarter-of-fiscal-year-2024/]]></loc>
		<lastmod><![CDATA[2024-02-13T23:02:57+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/news-2023/]]></loc>
		<lastmod><![CDATA[2024-02-13T20:56:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/06/Appili-Banner-3.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/12/15/appili-therapeutics-announces-issuance-of-patent-for-ati-1701-biodefense-vaccine-candidate-to-protect-against-tularemia-and-provides-update-on-bridge-loan/]]></loc>
		<lastmod><![CDATA[2023-12-15T12:30:45+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/11/13/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2024/]]></loc>
		<lastmod><![CDATA[2023-11-13T22:05:28+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/09/25/appili-therapeutics-announces-u-s-fda-approval-of-likmez-ati-1501-metronidazole-oral-suspension/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:13:15+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/04/03/appili-therapeutics-appoints-dr-gary-nabors-as-chief-development-officer/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:08:36+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/04/18/appili-therapeutics-to-present-at-the-2023-bloom-burton-co-healthcare-investor-conference/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:08:30+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/05/08/appili-therapeutics-secures-contract-for-ati-1701-funding-from-the-u-s-air-force-academy/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:08:23+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/05/24/appili-therapeutics-announces-issuance-of-patent-for-ati-1501-liquid-oral-reformulation-of-metronidazole/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:08:12+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/06/23/appili-therapeutics-reports-fiscal-year-2023-financial-and-operational-results/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:08:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/06/29/appili-therapeutics-announces-bridge-loan-from-bloom-burton-co/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:07:52+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/08/11/appili-therapeutics-reports-financial-and-operational-results-for-first-quarter-of-fiscal-year-2024/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:07:44+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/06/Appili-Banner-3.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/09/27/appili-therapeutics-presents-at-the-10th-international-tularemia-conference/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:07:23+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/09/27/appili-therapeutics-announces-results-of-annual-meeting-of-shareholders-and-provides-corporate-update/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:07:15+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/10/25/appili-therapeutics-biodefense-vaccine-candidate-ati-1701-is-awarded-additional-funding-from-the-u-s-air-force-academy/]]></loc>
		<lastmod><![CDATA[2023-10-30T20:07:10+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/ati-1701/]]></loc>
		<lastmod><![CDATA[2023-10-30T19:53:10+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/Group-66.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/elementor/thumbs/USAFA2-1-q3ny7ain63107ib3s5typvm8v2qaw6ow3roznb5sds.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/Rectangle-59.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/US-DOD.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/DTRA2.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/Img-1.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/ati-1501/]]></loc>
		<lastmod><![CDATA[2023-10-25T18:42:57+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/3d295b_653f86589a3f4aa4bb304a188fd20821_mv2-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/4008d8_eddccb4af10b45b2adcaa82f5e6b67e9_mv2-1.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/ati-1801/]]></loc>
		<lastmod><![CDATA[2023-06-27T15:05:35+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/06/Appili-Banner-3.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/img-2-e1672403378374.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/quote-svgrepo-com-2-1-e1672404168611.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/quote-svgrepo-com-2-3.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2016-2020/]]></loc>
		<lastmod><![CDATA[2023-05-08T15:23:26+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2021/appili-therapeutics-to-present-at-the-2023-bloom-burton-co-healthcare-investor-conference/]]></loc>
		<lastmod><![CDATA[2023-04-18T11:20:58+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/analyst-coverage/]]></loc>
		<lastmod><![CDATA[2023-04-17T18:08:35+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/contact/]]></loc>
		<lastmod><![CDATA[2023-04-11T16:25:26+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/plugins/wpforms/assets/images/submit-spin.svg]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/contact-2/]]></loc>
		<lastmod><![CDATA[2023-04-11T15:56:10+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/plugins/wpforms/assets/images/submit-spin.svg]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/03/20/appili-therapeutics-announces-additional-funding-of-cad2-5-million-under-non-convertible-secured-loan-with-long-zone-holdings/]]></loc>
		<lastmod><![CDATA[2023-04-11T13:56:45+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/corporate-governance/]]></loc>
		<lastmod><![CDATA[2023-04-11T13:51:27+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/business-environment/]]></loc>
		<lastmod><![CDATA[2023-04-11T12:26:45+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2022/12/Group-95-3.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/strategy/]]></loc>
		<lastmod><![CDATA[2023-04-11T12:25:24+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/ApilliTherapeutics-Balanced-Risk-1-1.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/latest-events-post-1/]]></loc>
		<lastmod><![CDATA[2023-03-31T10:09:33+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/legal-counsel-auditors/]]></loc>
		<lastmod><![CDATA[2023-03-28T13:21:49+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/collaborators/]]></loc>
		<lastmod><![CDATA[2023-03-28T12:31:22+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/Group-71.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/03/Collaborators.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/02/27/appili-ceo-attends-capital-events-investor-conference/]]></loc>
		<lastmod><![CDATA[2023-03-27T14:31:47+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/11/14/appili-therapeutics-ati-1701-biodefense-vaccine-secures-us14-million-of-funding-from-the-u-s-department-of-defense-in-partnership-with-the-u-s-air-force-academy/]]></loc>
		<lastmod><![CDATA[2023-03-24T19:40:23+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/01/13/appili-therapeutics-announces-notice-of-allowance-from-the-u-s-patent-and-trademark-office-for-ati-1501-liquid-oral-reformulation-of-metronidazole/]]></loc>
		<lastmod><![CDATA[2023-03-24T19:40:14+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/01/17/appili-therapeutics-appoints-dr-carl-gelhaus-and-arthur-baran-to-support-the-ati-1701-biodefense-vaccine-program/]]></loc>
		<lastmod><![CDATA[2023-03-24T19:40:03+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/02/08/appili-therapeutics-announces-that-fda-accepts-the-ati-1501-nda/]]></loc>
		<lastmod><![CDATA[2023-03-24T19:39:46+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2023/02/14/appili-therapeutics-reports-financial-and-operational-results-for-third-quarter-of-fiscal-year-2023/]]></loc>
		<lastmod><![CDATA[2023-03-24T19:34:12+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/fireside-chat-press-kit/]]></loc>
		<lastmod><![CDATA[2023-03-09T09:24:13+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-5.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-8-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-6.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-7.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/2.jpg]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/3.jpg]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/4.jpg]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/1.jpg]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/Bloom-Burton-Logo-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/Dentons-Logo-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/Appili-Fireside-Chat-Series-1-Fact-Sh-1.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/media-download-center/]]></loc>
		<lastmod><![CDATA[2023-03-09T09:22:49+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/svgviewer-output-12-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/svgviewer-output-13-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/svgviewer-output-14-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/svgviewer-output-15-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2022/12/logo.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2022/12/logo-b-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-1-150x150.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-2-150x150.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-3-150x150.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://z5w.be6.myftpupload.com/wp-content/uploads/2023/01/MEMBER-4-150x150.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/media-contact/]]></loc>
		<lastmod><![CDATA[2023-03-09T09:20:31+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/plugins/wpforms/assets/images/submit-spin.svg]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2016/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:33:19+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2017/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:32:56+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2018/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:32:34+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2019/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:32:13+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2020/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:31:51+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/archives-2021/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:31:18+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/news-2022/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:29:02+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/submit-resume/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:08:00+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/plugins/wpforms/assets/images/submit-spin.svg]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/career-opportunities/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:07:44+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/careers/]]></loc>
		<lastmod><![CDATA[2023-03-09T08:06:56+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/img.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2016/12/21/appili-therapeutics-raises-2-2m-in-equity-capital-to-develop-its-anti-infective-pipeline/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:15:25+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2016/04/12/appili-receives-orphan-drug-designation-from-fda-for-ati-1501-treating-c-difficile-in-children/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:15:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2016/05/25/appili-raises-3-2m-in-seed-round-to-develop-novel-antibiotics/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:14:59+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2016/10/03/appili-therapeutics-inc-appoints-kimberly-stephens-as-chief-financial-officer/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:14:53+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/01/06/appili-therapeutics-inc-appoints-industry-veteran-stephen-nicolle-to-its-board-2/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:14:28+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/04/11/appili-therapeutics-receives-funding-from-the-government-of-canada-to-support-development-of-new-antibiotic-to-treat-gram-negative-infections/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:14:13+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/04/19/appili-therapeutics-to-present-at-the-bloom-burton-co-healthcare-investor-conference/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:13:57+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/07/06/appili-therapeutics-inc-appoints-pharmaceutical-executive-sean-mcbride-as-vice-president-business-development/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:13:45+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/09/08/appili-announces-results-of-2017-agm/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:13:28+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/10/23/appili-therapeutics-raises-3m-to-advance-its-anti-infective-pipeline/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:13:18+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/10/30/appili-receives-fda-and-health-canada-clearance-to-begin-clinical-trials-of-its-antibiotic-oral-liquid-reformulation/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:13:01+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/11/07/appili-therapeutics-receives-1-2m-usd-from-the-department-of-defense-to-advance-antibiotic-targeting-drug-resistant-bacteria/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:12:19+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/11/28/appili-therapeutics-appoints-seasoned-biotech-executive-ian-c-mortimer-to-its-board/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:11:47+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/01/09/appili-therapeutics-licenses-bioterrorism-vaccine-rights/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:10:50+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/01/26/appili-recognized-as-new-business-of-the-year-by-the-halifax-chamber-of-commerce/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:10:07+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/02/07/appili-therapeutics-raises-an-additional-4-3-million-in-oversubscribed-financing-to-advance-its-anti-infective-pipeline/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:09:20+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/04/18/appili-therapeutics-to-present-at-2018-bloom-burton-co-healthcare-investor-conference/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:09:08+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/06/21/appili-therapeutics-to-present-at-2018-atlantic-venture-forum-technology-showcase/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:08:55+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/07/30/appili-therapeutics-completes-phase-1-study-for-ati-1501-its-taste-masked-oral-metronidazole-suspension/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:08:43+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/08/16/appili-therapeutics-announces-results-of-2018-annual-and-special-meeting/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:07:59+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2018/10/01/appili-therapeutics-appoints-veteran-drug-development-executive-dr-armand-balboni-as-its-inaugural-chief-scientific-officer/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:07:48+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/03/25/appili-therapeutics-announces-closing-of-3-6-million-special-warrant-private-placement-and-filing-of-preliminary-prospectus/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:07:25+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/04/08/appili-therapeutics-to-present-at-2019-bloom-burton-co-healthcare-investor-conference/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:07:05+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/04/10/appili-therapeutics-receives-government-of-canada-assistance-to-support-continued-growth-of-its-novel-anti-infective-pipeline/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:06:43+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/06/13/appili-therapeutics-announces-filing-of-final-prospectus/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:06:08+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/06/24/appili-therapeutics-common-shares-to-begin-trading-on-june-25-2019-on-the-tsxv-under-the-stock-symbol-apli/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:05:43+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/07/02/appili-therapeutics-signs-3m-usd-grant-contract-with-the-united-states-department-of-defense-to-develop-antibiotics-that-target-superbugs/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:05:19+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/07/03/appili-therapeutics-announces-fy-2019-financial-results/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:04:56+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/08/20/researchers-to-present-new-data-on-appili-therapeutics-infectious-disease-programs-at-the-2019-military-health-system-research-symposium/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:04:22+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/08/21/appili-therapeutics-reports-financial-results-for-first-quarter-of-fiscal-year-2020/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:03:56+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/09/16/appili-therapeutics-retains-bnd-projects-for-strategic-investor-relations-services/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:03:33+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/09/26/appili-therapeutics-announces-voting-results-of-annual-and-special-meeting-of-shareholders/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:03:09+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/11/18/researchers-present-new-positive-interim-data-on-appili-therapeutics-ati-1701-biodefense-program-at-2019-chemical-and-biological-defense-science-technology-conference/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:02:48+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/11/21/appili-therapeutics-acquires-clinical-stage-antifungal-program-from-fujifilm-toyama-chemical/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:02:05+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/11/27/appili-therapeutics-reports-financial-results-for-second-quarter-of-fiscal-year-2020/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:00:51+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/12/02/appili-therapeutics-names-dr-armand-balboni-as-chief-executive-officer/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:00:25+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2019/12/03/appili-therapeutics-enters-commercial-agreement-with-saptalis-pharmaceuticals-for-anticipated-launch-of-ati-1501-antibiotic-candidate-in-the-u-s/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:59:11+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/01/07/appili-celebrates-a-notable-2019-and-looks-ahead-to-significant-milestones-in-2020/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:58:44+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/01/27/appili-therapeutics-appoints-veteran-biotech-executive-dr-juergen-froehlich-to-its-board-of-directors/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:58:32+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/01/28/researchers-present-positive-interim-data-on-appili-therapeutics-ati-1701-biodefense-program-at-2020-asm-biothreats/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:57:39+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/02/12/appili-therapeutics-announces-overnight-marketed-equity-offering-in-february-2020/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:57:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/02/14/appili-therapeutics-announces-upsizing-of-previously-announced-equity-offering-in-february-2020/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:56:29+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/02/20/appili-therapeutics-announces-closing-of-public-offering-of-10250000/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:56:03+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/02/27/appili-therapeutics-reports-financial-and-operational-results-for-third-quarter-fiscal-year-2020-copy/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:55:36+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/04/21/appili-therapeutics-names-infectious-disease-specialist-yoav-golan-md-as-its-chief-medical-officer/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:55:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/05/04/appili-therapeutics-to-present-at-maxim-groups-infectious-disease-virtual-conference/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:54:47+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/05/11/appili-therapeutics-submits-cta-with-health-canada-to-sponsor-prophylactic-phase-2-clinical-trial-evaluating-fujifilm-toyama-chemicals-favipiravir-as-a-preventative-measure-against-covid-19-i/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:54:18+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/05/21/health-canada-clears-appili-therapeutics-phase-2-clinical-trial-evaluating-favipiravir-as-a-prophylactic-agent-against-covid-19-outbreaks/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:53:18+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/06/03/appili-therapeutics-announces-overnight-marketed-equity-offering-3/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:01:55+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/06/04/appili-therapeutics-announces-pricing-of-overnight-marketed-equity-offering-in-june-2020/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:01:41+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/06/05/appili-therapeutics-announces-filing-of-prospectus-supplement-and-proposed-concurrent-private-placement/]]></loc>
		<lastmod><![CDATA[2023-03-09T06:01:08+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/06/10/appili-therapeutics-announces-closing-of-public-offering-of-15525000-and-concurrent-private-placement-of-1440000/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:45:32+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/06/15/appili-therapeutics-commences-trading-on-the-otcqx-marketplace/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:44:59+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/06/24/appili-therapeutics-announces-fy-2020-annual-and-financial-results/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:37:25+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/08/10/fda-clears-appili-therapeutics-to-expand-its-phase-2-clinical-trial-of-favipiravir-for-the-potential-prevention-of-covid-19-at-u-s-long-term-care-facilities/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:36:16+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/08/11/appili-therapeutics-receives-eligibility-for-dtc-trading-in-the-u-s/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:35:41+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/08/13/appili-therapeutics-announces-voting-results-of-annual-and-special-meeting-of-shareholders-2/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:34:27+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/08/14/appili-therapeutics-reports-financial-and-operational-results-for-first-quarter-of-fiscal-year-2021/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:34:09+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/09/10/appili-therapeutics-to-participate-in-upcoming-investor-conferences-for-h-c-wainwright-co-and-maxim-group-llc/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:33:48+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/09/11/appili-submits-protocol-for-a-phase-3-study-evaluating-favipiravir-for-the-treatment-of-patients-with-covid-19-infections-to-the-us-fda/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:33:24+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/09/14/appili-therapeutics-to-commence-trading-on-main-board-of-the-tsx-exchange/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:33:01+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/10/20/first-participants-dosed-in-appili-therapeutics-phase-2-clinical-trial-evaluating-favipiravir-for-covid-19-outbreak-control-in-canadian-long-term-care-homes/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:32:42+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/10/27/appili-therapeutics-announces-additional-funding-for-its-ati-1701-biodefense-program/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:31:56+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/10/27/appili-therapeutics-to-present-at-tsx-life-sciences-investor-day/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:31:29+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/10/29/appili-therapeutics-appoints-drug-development-executive-don-cilla-to-the-newly-created-position-of-chief-development-officer/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:31:05+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/10/30/appili-therapeutics-joins-dr-reddys-global-response-aid-and-fujifilm-in-advancing-avigan-tablets-for-the-potential-treatment-of-covid-19/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:30:41+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/11/13/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2021/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:29:53+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/11/24/health-canada-clears-appili-therapeutics-for-new-phase-3-clinical-trial-to-evaluate-avigan-tablets-favipiravir-in-the-prevention-of-covid-19-in-exposed-individuals-in-the-community/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:29:23+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/12/02/first-patient-dosed-in-appili-therapeutics-phase-3-clinical-trial-of-avigan-tablets-favipiravir-for-the-treatment-of-covid-19-in-the-united-states/]]></loc>
		<lastmod><![CDATA[2023-03-09T05:26:11+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/12/22/dr-reddys-laboratories-global-response-aid-and-appili-therapeutics-announce-the-filing-of-an-application-for-reeqonus-favipiravir-tablets-for-the-treatment-of-covid-19-under-health-can/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:35:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/04/19/appili-therapeutics-to-present-at-the-bloom-burton-co-healthcare-investor-virtual-conference-on-wednesday-april-21st-2021/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:32:57+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/05/17/independent-data-safety-monitoring-board-recommends-appili-therapeutics-complete-its-phase-3-avigan-reeqonus-trial-for-mild-to-moderate-covid-19-patients/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:32:19+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/06/17/appili-therapeutics-inc-expands-preseco-clinical-trial-of-avigan-reeqonus-for-mild-to-moderate-covid-19-patients-into-mexico-and-brazil/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:31:48+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/06/24/appili-therapeutics-reports-fiscal-year-2021-financial-and-operational-results-provides-update-on-strategy-for-fiscal-2022/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:30:56+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/08/09/appili-therapeutics-secures-3-5-million-in-funding/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:29:11+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/08/13/appili-therapeutics-reports-financial-and-operational-results-for-first-quarter-of-fiscal-year-2022/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:28:06+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/08/18/appili-therapeutics-announces-closing-of-3-5-million-funding-agreement/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:26:19+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/09/08/appili-therapeutics-announces-results-for-resolutions-at-annual-general-meeting-of-shareholders/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:24:08+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/09/17/appili-therapeutics-announces-completion-of-patient-enrollment-for-avigan-reeqonus-viral-shedding-sub-study-for-mild-to-moderate-covid-19-patients/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:23:43+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/09/20/appili-therapeutics-announces-agreement-with-fujifilm-and-funding-support-for-clinical-trial-program-evaluating-avigan-reeqonus-for-covid-19-patients/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:23:00+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/09/23/appili-therapeutics-announces-last-patient-enrolled-in-phase-3-trial-of-oral-avigan-reeqonus-for-the-treatment-of-mild-to-moderate-covid-19/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:22:28+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/09/29/appili-therapeutics-and-aipharma-announce-strategic-alliance-and-equity-transaction/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:21:59+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/10/06/appili-therapeutics-announces-overnight-marketed-equity-offering-2/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:20:38+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/10/07/appili-therapeutics-announces-pricing-of-overnight-marketed-equity-offering-2/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:19:59+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/10/14/appili-therapeutics-announces-closing-of-public-offering-of-7000220/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:19:26+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/11/12/appili-therapeutics-provides-update-on-phase-3-preseco-clinical-trial-evaluating-avigan-reeqonus/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:12:51+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/11/12/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2022-and-change-of-chief-financial-officer/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:12:21+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/11/19/appili-therapeutics-announces-positive-one-year-challenge-results-from-preclinical-study-evaluating-biodefense-vaccine-candidate-ati-1701-and-change-to-board-of-directors/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:11:20+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/12/22/appili-therapeutics-announces-update-to-funding-agreement-with-the-lind-partners/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:10:51+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2021/12/23/appili-therapeutics-press-release-correction/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:09:58+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/02/08/appili-therapeutics-expands-ati-1501-commercial-agreement-with-partner-saptalis-pharmaceuticals/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:09:47+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/02/14/appili-therapeutics-reports-financial-and-operational-results-for-third-quarter-of-fiscal-year-2022/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:09:11+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/02/28/appili-therapeutics-announces-over-us10-million-in-new-funding-from-us-department-of-defense-for-biodefense-vaccine-candidate-ati-1701/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:08:45+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/03/09/appili-therapeutics-to-present-live-via-webcast-at-otc-markets-virtual-life-sciences-investor-forum/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:08:07+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/03/29/appili-therapeutics-announces-non-convertible-secured-loan-of-us3-6-million-and-license-and-distribution-agreement-with-long-zone-holdings/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:07:14+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/04/13/appili-therapeutics-announces-new-late-stage-clinical-program-ati-1801-to-treat-cutaneous-leishmaniasis/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:06:47+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/04/27/appili-therapeutics-to-present-at-the-2022-bloom-burton-co-healthcare-investor-conference/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:06:14+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/05/17/appili-therapeutics-announces-overnight-marketed-equity-offering/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:05:26+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/05/18/appili-therapeutics-announces-pricing-of-overnight-marketed-equity-offering/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:05:02+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/05/26/appili-therapeutics-announces-closing-of-public-offering-of-4500000/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:03:46+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/06/29/appili-therapeutics-reports-fiscal-year-2022-financial-and-operational-results/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:03:00+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/08/02/appili-therapeutics-to-present-at-worldleish7-conference-in-cartagena-columbia/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:02:17+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/08/12/appili-therapeutics-reports-financial-and-operational-results-for-first-quarter-of-fiscal-year-2023/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:01:26+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/09/22/appili-therapeutics-announces-results-of-annual-and-special-meeting-of-shareholders/]]></loc>
		<lastmod><![CDATA[2023-03-07T14:00:23+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2022/11/10/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2023/]]></loc>
		<lastmod><![CDATA[2023-03-07T13:59:59+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2020/07/30/appili-prepares-canadian-long-term-care-facilities-to-enroll-participants-in-a-clinical-trial-evaluating-favipiravir-as-an-outbreak-control-agent-against-covid-19/]]></loc>
		<lastmod><![CDATA[2023-02-18T08:59:51+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/2017/02/17/appili-therapeutics-awarded-2-8m-from-acoa-to-fund-clinical-trials/]]></loc>
		<lastmod><![CDATA[2023-02-16T05:52:30+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/social-media/]]></loc>
		<lastmod><![CDATA[2023-01-28T11:10:26+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/terms-of-use/]]></loc>
		<lastmod><![CDATA[2023-01-28T10:55:44+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/cookies/]]></loc>
		<lastmod><![CDATA[2023-01-28T10:53:22+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/privacy/]]></loc>
		<lastmod><![CDATA[2023-01-28T10:47:04+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/advisors/]]></loc>
		<lastmod><![CDATA[2023-01-24T10:39:35+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/uploads/2023/01/appili-1.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/demo/]]></loc>
		<lastmod><![CDATA[2023-01-11T09:53:21+00:00]]></lastmod>
		<changefreq><![CDATA[weekly]]></changefreq>
		<priority><![CDATA[0.7]]></priority>
		<image:image>
			<image:loc><![CDATA[http://appilitherapeutics.com/wp-content/uploads/2022/12/infectious.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://appilitherapeutics.com/wp-content/uploads/2022/12/img.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://appilitherapeutics.com/wp-content/uploads/2022/12/img-3.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://appilitherapeutics.com/wp-content/uploads/2022/12/img-4.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://appilitherapeutics.com/wp-content/uploads/2022/12/img-5.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://appilitherapeutics.com/wp-content/uploads/2022/12/Img-1.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[http://appilitherapeutics.com/wp-content/uploads/2022/12/img-7.png]]></image:loc>
		</image:image>
		<image:image>
			<image:loc><![CDATA[https://appilitherapeutics.com/wp-content/themes/twentytwenty-child/img/see_all_evet_arrow.png]]></image:loc>
		</image:image>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2025/]]></loc>
		<lastmod><![CDATA[2026-03-30T11:24:57+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/highlights/]]></loc>
		<lastmod><![CDATA[2026-03-30T11:24:57+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2020/]]></loc>
		<lastmod><![CDATA[2025-10-08T13:34:09+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/]]></loc>
		<lastmod><![CDATA[2025-10-08T13:34:09+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2024/]]></loc>
		<lastmod><![CDATA[2024-11-19T12:18:58+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2023/]]></loc>
		<lastmod><![CDATA[2023-12-15T12:30:45+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2022/]]></loc>
		<lastmod><![CDATA[2023-03-24T19:40:23+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2016/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:15:25+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2017/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:14:28+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2018/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:10:50+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2019/]]></loc>
		<lastmod><![CDATA[2023-03-09T07:07:25+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
	<url>
		<loc><![CDATA[https://appilitherapeutics.com/category/archives/archives-2021/]]></loc>
		<lastmod><![CDATA[2023-03-09T04:32:57+00:00]]></lastmod>
		<changefreq><![CDATA[monthly]]></changefreq>
		<priority><![CDATA[0.3]]></priority>
	</url>
</urlset>
